Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Long-Term Deferred Tax (2017 - 2023)

Historic Long-Term Deferred Tax for Silo Pharma (SILO) over the last 6 years, with Q4 2023 value amounting to $2.5 million.

  • Silo Pharma's Long-Term Deferred Tax rose 6373.74% to $2.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.5 million, marking a year-over-year increase of 6373.74%. This contributed to the annual value of $2.5 million for FY2023, which is 6373.74% up from last year.
  • Silo Pharma's Long-Term Deferred Tax amounted to $2.5 million in Q4 2023, which was up 6373.74% from $1.6 million recorded in Q4 2022.
  • Silo Pharma's 5-year Long-Term Deferred Tax high stood at $2.5 million for Q4 2023, and its period low was $609530.0 during Q4 2021.
  • For the 5-year period, Silo Pharma's Long-Term Deferred Tax averaged around $1.3 million, with its median value being $992271.0 (2020).
  • Per our database at Business Quant, Silo Pharma's Long-Term Deferred Tax tumbled by 3857.22% in 2021 and then surged by 15435.79% in 2022.
  • Silo Pharma's Long-Term Deferred Tax (Quarter) stood at $614751.0 in 2019, then skyrocketed by 61.41% to $992271.0 in 2020, then crashed by 38.57% to $609530.0 in 2021, then soared by 154.36% to $1.6 million in 2022, then skyrocketed by 63.74% to $2.5 million in 2023.
  • Its last three reported values are $2.5 million in Q4 2023, $1.6 million for Q4 2022, and $609530.0 during Q4 2021.